INmune Bio
Financial ratios & Valuation

Forward Multiples (2025 – 2028)

2025202620272028
Price/Earnings ratio
-0.94-0.981.770.59
Price/Sales ratio
1.48K1.45K0.510.29
Earnings per Share (EPS)
$-2.55$-2.45$1.36$4.06

Historical Multiples (2015 – 2023)

2015 2016 2017 2018 2019 2020 2021 2022 2023 TTM Median
Valuation Ratios
Price/Earnings ratio
-1.83K-323.04-107.81-7.20-6.51-17.06-5.42-3.96-6.74-5.07-6.86
Price/Sales ratio
N/AN/AN/AN/A0.7618.91K909.01303.901.30K370.68185.72
Price/Book Value ratio
-4.75K-600.814.955.412.525.322.051.895.302.303.92
Price/Cash Flow ratio
-4.94K-282.44-117.66-43.53-11.06-23.08-5.77-5.01-16.90-6.11-27.30
Price/Free Cash Flow ratio
-4.94K-282.44-104.01-43.53-11.06-23.08-3.78-5.01-16.90-6.11-27.30
Price/Earnings Growth ratio
N/A-0.70-0.53-0.000.32-1.26-0.060.26-1.54-0.31-0.46
Dividend Yield
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Profitability Indicator Ratios
Gross Profit Margin
N/AN/AN/AN/A100%100%100%100%100%N/A100%
Operating Profit Margin
N/AN/AN/AN/A-9.98%-112016.08%-16106.62%-6938.77%-19187.74%-6938.77%-3474.37%
Pretax Profit Margin
N/AN/AN/AN/A-9.88%-110838.75%-16762.43%-7299.19%-19360%-7299.19%-3654.54%
Net Profit Margin
N/AN/AN/AN/A-11.76%-110838.75%-16762.43%-7659.62%-19360%-7299.19%-3655.48%
Effective Tax Rate
N/A63.96%136.07%1.29%-19.07%101.06%96.08%-4.93%N/AN/A-9.53%
Return on Assets
-411.27%-61.44%-4.51%-71.64%-37.36%-29.75%-30.35%-35.02%-52.64%-33.37%-54.50%
Return On Equity
258.99%185.98%-4.59%-75.21%-38.72%-31.22%-37.81%-47.66%-78.68%-40.53%-34.97%
Return on Capital Employed
259.01%152.47%-5.42%-75.21%-32.62%-31.45%-30.49%-36.61%-77.17%-36.61%-32.03%
Liquidity Ratios
Current Ratio
N/AN/AN/AN/A11.0813.50N/AN/AN/A5.9212.29
Quick Ratio
0.380.756.131.031.10K1.14K20.215.922.165.551.12K
Cash ratio
0.380.234.420.229.9812.3617.164.771.944.7711.17
Days of Sales Outstanding
N/AN/AN/AN/A3.0360.15K11.09K8.25K5.75K8.25K4.13K
Days of Inventory outstanding
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Operating Cycle
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Days of Payables Outstanding
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Cash Conversion Cycle
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Debt Ratios
Debt Ratio
N/A0.77N/AN/AN/AN/A0.140.180.170.26N/A
Debt Equity Ratio
N/A-2.34N/AN/AN/AN/A0.180.240.260.36N/A
Long-term Debt to Capitalization
N/AN/AN/AN/AN/AN/A0.150.13N/A0.14N/A
Total Debt to Capitalization
N/A1.74N/AN/AN/AN/A0.150.190.200.20N/A
Interest Coverage Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Cash Flow to Debt Ratio
N/A-0.90N/AN/AN/AN/A-1.96-1.53-1.19-1.48N/A
Company Equity Multiplier
-0.62-3.021.011.041.031.041.241.361.491.361.04
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
N/AN/AN/AN/A-0.06-819.31-157.48-60.65-77.29-60.65-30.36
Free Cash Flow / Operating Cash Flow Ratio
111.131111.521111
Cash Flow Coverage Ratio
N/A-0.90N/AN/AN/AN/A-1.96-1.53-1.19-1.48N/A
Short Term Coverage Ratio
N/A-0.90N/AN/AN/AN/A-395.88-4.45-1.19-4.45N/A
Dividend Payout Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A